Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bierman

Showing results (91-100 of 253) with videos related to

Pageof 26
Sort By:
American Journal of Clinical Oncology|December 1, 1991
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphomaR M Bashir, P J Bierman, J M Vose, et al.
Nederlands Tijdschrift Voor Tandheelkunde|January 14, 2005
[Distraction osteogenesis of the maxilla in cleft patients. Worth considering]W W I Kalk, J de Lange, J Jansma, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Transmembrane signalling by growth factorsW H Moolenaar, L H Defize, B C Tilly, et al.
Journal of Personality and Social Psychology|July 1, 1983
The roles of self-esteem and self-consciousness in the Wortman-Brehm model of reactance and learned helplessnessJ Brockner, M Gardner, J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphomaP J Bierman, J M Vose, J R Anderson, et al.
Seminars in Oncology|June 1, 1992
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agentW P Vaughan, P J Bierman, E C Reed, et al.
Leukemia & Lymphoma|April 25, 2007
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantationJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Environmental Science & Technology|April 9, 2009
Engineered nanomaterial transformation under oxidative environmental conditions: development of an in vitro biomimetic assayKevin M Metz, Andrew N Mangham, Matthew J Bierman, et al.
Blood|September 1, 1989
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphomaA Kessinger, J O Armitage, D M Smith, et al.
Nature|September 11, 1986
Growth factor-like action of phosphatidic acidW H Moolenaar, W Kruijer, B C Tilly, et al.
Pageof 26

Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
American Journal of Clinical Oncology|December 1, 1991
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphomaR M Bashir, P J Bierman, J M Vose, et al.
Nederlands Tijdschrift Voor Tandheelkunde|January 14, 2005
[Distraction osteogenesis of the maxilla in cleft patients. Worth considering]W W I Kalk, J de Lange, J Jansma, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Transmembrane signalling by growth factorsW H Moolenaar, L H Defize, B C Tilly, et al.
Journal of Personality and Social Psychology|July 1, 1983
The roles of self-esteem and self-consciousness in the Wortman-Brehm model of reactance and learned helplessnessJ Brockner, M Gardner, J Bierman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphomaP J Bierman, J M Vose, J R Anderson, et al.
Seminars in Oncology|June 1, 1992
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agentW P Vaughan, P J Bierman, E C Reed, et al.
Leukemia & Lymphoma|April 25, 2007
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantationJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Environmental Science & Technology|April 9, 2009
Engineered nanomaterial transformation under oxidative environmental conditions: development of an in vitro biomimetic assayKevin M Metz, Andrew N Mangham, Matthew J Bierman, et al.
Blood|September 1, 1989
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphomaA Kessinger, J O Armitage, D M Smith, et al.
Nature|September 11, 1986
Growth factor-like action of phosphatidic acidW H Moolenaar, W Kruijer, B C Tilly, et al.
Pageof 26